Skip to main content

and
  1. No Access

    Chapter

    Status and Progress

    In 2021, China’s in vitro diagnostics (IVD) industry had significant progress and development in all aspects. China Association of In Vitro Diagnostics and In Vitro Diagnostics Society of China Association for...

    Haibo Song, Yaoyi Zhu, Linda Zhang, Qi Chen in In Vitro Diagnostic Industry in China (2023)

  2. No Access

    Chapter

    Clinical Chemistry Laboratory Automation

    Total laboratory automation (TLA) refers to the integration of different testing platforms, pre-analysis, and post-analysis sample processing modules through automated transmission tracks and information netwo...

    Wei Qin, Jianmei Zhang, Ye Sheng, Jianer Yao in In Vitro Diagnostic Industry in China (2023)

  3. No Access

    Chapter

    Classification and Status of IVD Reagent Raw Materials

    In 2019 and 2020, the in vitro diagnostic (IVD) industry presented a trend of accelerated growth due to the impact of Coronavirus Disease-2019 (COVID-19). In 2019, the market size of the IVD industry increased...

    Guangyu Yang, Hongsen **, Shuai Han in In Vitro Diagnostic Industry in China (2023)

  4. No Access

    Chapter

    Development Bottlenecks and Favorable Factors of IVD Reagent Raw Materials

    Core in vitro diagnostic (IVD) reagent raw materials constitute the basis for the research and development (R&D) and innovation of IVD reagents, and belong to the field of basic disciplines that require long-t...

    Guangyu Yang, Hongsen **, Shuai Han in In Vitro Diagnostic Industry in China (2023)

  5. No Access

    Chapter

    Blood Coagulation Analyzer and Reagents

    Conventional thrombosis and hemostasis diagnostic applications are mainly concentrated on screening for bleeding disorders and diagnosis of bleeding origins, with a relatively narrow scope of application and r...

    Zuojun Zou, Yanshang Ma, Qifan Tian, Hai Wang in In Vitro Diagnostic Industry in China (2023)

  6. No Access

    Chapter

    Development and Application Status of National Reference Materials for in Vitro Diagnostic Reagents

    In vitro diagnosis refers to the activity of analyzing and testing samples (blood, body fluids, tissues, etc.) taken from a human body by means of chemical, physical, or biological analysis, so as to evaluate ...

    Jian Zhang, Junli Zu, Gongcheng Liu in In Vitro Diagnostic Industry in China (2023)

  7. No Access

    Chapter

    Opportunities and Challenges

    With the coronavirus disease 2019 (COVID-19) outbreak in all countries worldwide and influenced by factors such as the global political environment, economy, technological innovation, and the Internet, in vitr...

    Yaoyi Zhu, Linda Zhang, Qi Chen, Wenting **ao in In Vitro Diagnostic Industry in China (2023)

  8. No Access

    Chapter

    Research and Development, Production, and Application Status of Quality Controls for in Vitro Diagnostic Reagents

    As per requirements of ISO15189 Medical Laboratories-Requirements for Quality and Competence (2012), clinical laboratories providing medical laboratory services should meet the basic requirements of quality manag...

    Junli Zu, Jian Zhang, Gongcheng Liu in In Vitro Diagnostic Industry in China (2023)

  9. No Access

    Chapter

    Molecular Diagnosis of Novel Coronavirus

    The novel coronavirus is a positive-strand RNA virus, which is the seventh coronavirus known to infect humans [1] and is the thirteenth β-CoV. It can be directly translated to generate RNA polymerase for RNA t...

    Lizhong Dai, Zhong** Deng, Jia Liu, in In Vitro Diagnostic Industry in China (2023)

  10. No Access

    Chapter

    Molecular Diagnostic Analyzers and Reagents

    Molecular diagnostics uses human saliva, tissue, blood, feces, urine, and other samples to detect disease-related markers and provides experimental diagnostic results for medical professionals in disease preve...

    Jack Shao, Qiang Li, Jie Zhang, Zhong** Deng in In Vitro Diagnostic Industry in China (2023)

  11. No Access

    Chapter

    Drug Repurposing in Cancer

    The discovery of drug compounds has a long history in drug repurposing, notably by fortuitous findings. It has taken a new path in the creation of novel therapeutics based on existent or authorized drugs in re...

    N. R. Shruthi, M. Samatha Jain in Drug Repurposing for Emerging Infectious D… (2023)

  12. No Access

    Chapter

    Breast Cancer

    Breast cancer remains a predominant cancer in women worldwide. In China, the incidence of breast cancer continues to increase and is predicted to double mortality rates in coming years. Breakthrough research h...

    **ao Zou, Renmin Wei, Ketao Lan, Xuezhen Ma in Alternative and Complementary Therapies fo… (2010)

  13. No Access

    Chapter

    The Immunological Modulation of Fuzheng TCM Herbs in Cancer Treatment

    Reinforcing healthy Qi and replenishing archaeus is an important principle of immunoregulation therapy in cancer treatment by TCM. Immune regulation of single Chinese herbs of cancer patients is discussed. The...

    Hongsheng Lin MD, Jie Li PHD, Ying Zhang PHD in Dietary Components and Immune Function (2010)

  14. No Access

    Chapter

    Marine Natural Products and their Synthetic Derivatives for Cancer Therapy

    The ocean, which covers approximately 70% of the Earth’s surface, is a natural treasury of resources that houses about 80% of all the varieties of life on our planet. The past 20 years have seen a decrease in ...

    Tao Jiang, Puyong Zhang, Shaopeng Chen in Alternative and Complementary Therapies fo… (2010)

  15. No Access

    Chapter

    Fluoropyrimidine catabolism

    Antimetabolites are a class of chemotherapeutic agents that have a chemical structure similar to physiologic intermediates and can function as substrates for important enzymatic reactions required in vital cel...

    Robert B. Diasio, Zhihong Lu, Ruiwen Zhang in Concepts, Mechanisms, and New Targets for … (1995)